EGEnisa Gutic
Enisa Gutic
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Enisa Gutic has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Angelika Schütz
Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria
2 shared publications - Caroline Schwarz
Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine IV, Klinik Ottakring, Vienna, Austria
2 shared publications - Hans Haltmayer
Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria
2 shared publications - Michael Gschwantler
Klinik Ottakring, Department of Internal Medicine IV, Vienna, Austria
2 shared publications - Raphael Schubert
Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria
2 shared publications - Thomas Reiberger
Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
2 shared publications
Latest Publications
- Open Access
- 27 July 2023
- Published by Elsevier in Journal of Virus Eradication
- Vol. 9 (3) , 100338
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers
- 27 July 2023
- Published by Elsevier in Journal of Virus Eradication
- Vol. 9 (3) , 100338
Open AccessCHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers
- Open Access
- 1 March 2023
- Published by Elsevier in Journal of Virus Eradication
- Vol. 9 (1) , 100319
Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy
- 1 March 2023
- Published by Elsevier in Journal of Virus Eradication
- Vol. 9 (1) , 100319
Open AccessCombining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy